Description
Form: Ready to use vial | Purity: ≥99% | Storage: Refrigerate
What It Is
Tesamorelin is a stabilized GHRH analog that is FDA-approved for the treatment of HIV-associated lipodystrophy (excess visceral fat). It is the only growth hormone secretagogue with FDA approval for a specific medical indication, which gives it a uniquely strong clinical evidence base.
What It Does
Tesamorelin reduces visceral fat (the deep abdominal fat around organs), improves body composition, increases IGF-1 levels, and improves cognitive function. Clinical trials showed a 15 to 18 percent reduction in visceral fat over 26 weeks. It also has neuroprotective effects and has been studied for cognitive decline and Alzheimer’s prevention.
How It Works
Tesamorelin binds to GHRH receptors in the pituitary and stimulates growth hormone release. The resulting GH pulse increases IGF-1 production in the liver, which drives fat metabolism, protein synthesis, and tissue repair. The visceral fat reduction is driven by GH-stimulated lipolysis in adipose tissue.
Who Benefits Most
People with significant visceral fat who have not responded to diet and exercise alone. Adults with age-related GH decline. People interested in cognitive protection and longevity. Athletes looking to improve body composition and recovery. People with metabolic syndrome or insulin resistance.
Protocol and Dosing
Typical dose: 1 to 2 mg injected subcutaneously once daily. Often stacked with Ipamorelin for enhanced GH output. Cycle length: 3 to 6 months.
| Vial Format | Total mg | Concentration | 1 mg dose | 2 mg dose |
|---|---|---|---|---|
| Standard vial | 5 mg | Reconstitute with 2.5 mL BAC water = 2 mg/mL | 0.5 mL / 50 units | 1 mL / 100 units |
Cautions
May cause water retention, joint aches, or tingling. Avoid if you have active cancer or a history of pituitary tumors. Not recommended during pregnancy. Monitor IGF-1 levels during use.
Pairs Well With
Ipamorelin for enhanced GH output through dual pathway stimulation. Semaglutide or Tirzepatide for comprehensive metabolic and fat loss protocols. MOTS-C for mitochondrial and metabolic synergy.
Quality and Sourcing
Sourced through United Medical Services (UMS), a compounding facility built to the same standards as a licensed 503A pharmacy. Every batch is tested for purity, sterility, potency, and identity. Certificates of Analysis are available on request.
- HPLC purity testing
- LC-MS identity confirmation
- Sterility and endotoxin testing
- Heavy metals screening
- Purity: greater than or equal to 99%
For research and investigational use by qualified healthcare practitioners only. Not for human consumption. Not for resale. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Certificate of Analysis available on request. Questions? Call or text 507-382-2881.
Reviews
There are no reviews yet.